drugset / Trial / NCT02514200

Treatment of Keratoconus With Advanced CXL-II

NCT02514200

Phase 2 Unknown 50 enrolled Umeå University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether individualized, topography-based corneal crosslinking for keratoconus can improve the optical outcomes of the treatment.

Timeline

Start
2014-03
Primary completion
2019-10
Completion
2019-10

Drugs

EvaluationDrugModalityDoseRoute
Background Riboflavin Other / unclassified Topical

Indications